Evidence map›Paper›PMID 30353454›Full record

ArticleEating and weight disorders : EWD2019

DRD2/ANKK1 TaqI A1 polymorphism associates with overconsumption of unhealthy foods and biochemical abnormalities in a Mexican population.

Ingrid Rivera-Iñiguez, Arturo Panduro, Omar Ramos-Lopez, Sergio Javier Villaseñor-Bayardo, Sonia Roman

Abstract read
PubMed Publisher
In one paragraph

Article in Eating and weight disorders : EWD, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Prenatal Effects of Nicotine on Obesity Risks: A Narrative Review.International journal of environmental research and public health · 2022
    Review
  10. Article
  11. Article
  12. Review
  13. Dopaminergic Pathways in Obesity-Associated Inflammation.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Review
  14. Impact ofPharmacogenomics and personalized medicine · 2020
    Article
  15. Interactions betweenNutrients · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ingrid Rivera-IñiguezDepartment of Molecular Biology in Medicine, Civil Hospital of Guadalajara, "Fray Antonio Alcalde", Hospital #278, 44280, Guadalajara, Jalisco, Mexico.ORCID http://orcid.org/0000-0001-6129-6528
Arturo PanduroDepartment of Molecular Biology in Medicine, Civil Hospital of Guadalajara, "Fray Antonio Alcalde", Hospital #278, 44280, Guadalajara, Jalisco, Mexico.ORCID http://orcid.org/0000-0003-4784-748X
Omar Ramos-LopezDepartment of Molecular Biology in Medicine, Civil Hospital of Guadalajara, "Fray Antonio Alcalde", Hospital #278, 44280, Guadalajara, Jalisco, Mexico.ORCID http://orcid.org/0000-0002-2505-1555
Sergio Javier Villaseñor-BayardoHealth Sciences Center, University of Guadalajara, Guadalajara, Jalisco, Mexico.ORCID http://orcid.org/0000-0003-2206-6628
Sonia RomanDepartment of Molecular Biology in Medicine, Civil Hospital of Guadalajara, "Fray Antonio Alcalde", Hospital #278, 44280, Guadalajara, Jalisco, Mexico. soniamariaroman@hotmail.com.ORCID http://orcid.org/0000-0001-7061-6634
Universidad de Guadalajara · MX

Funding

PRODEP-UNIVERSIDAD DE GUADALAJARA CA478
6 · The paper itself

Abstract

purposeThe dopamine receptor 2/ankyrin repeat domain and content kinase 1 (DRD2/ANKK1) TaqIA polymorphism (rs1800497) has been associated with rewarding behaviors. This study aimed to investigate the association of DRD2/ANKK1 TaqIA polymorphism with the dietary intake, the intake frequency of food groups and biochemical profile in Mexican mestizo subjects.

methodsA cross-sectional/analytical study with 276 Mexican subjects was performed. Dietary intake was assessed with a 24-h recall and a food frequency questionnaire (FFQ). An allelic discrimination assay evaluated DRD2/ANKK1 TaqIA genotypes. Anthropometric and biochemical data were evaluated.

resultsGenotype frequencies were A1A1 (18.48%), A1A2 (45.29%) and A2A2 (36.23%). TaqI A1 allele carriers had a higher intake of carbohydrates (p = 0.038), meats (p = 0.005), fried dishes (p = 0.039), and sugars (p = 0.009). Male TaqI A1 carriers consumed more carbohydrates (p = 0.009) and meats (p = 0.018) while females consumed fewer legumes (p = 0.005). TaqI A1 carriers had glucose (p = 0.037) and triglycerides (p = 0.011) abnormalities. TaqI A1 was associated with higher risk of consumption of unhealthy foods such as fried dishes (OR 3.79, 95% CI 1.53-9.35, p = 0.002) and meats (OR 2.31, 95% CI 1.32-4.05, p = 0.003), and lower healthy foods (OR 1.89, 95% CI 1.04-3.29, p = 0.038). TaqI A1 allele was associated with risk of abnormal glucose, triglycerides, and VLDL levels (OR 2.148, 95% CI 1.068-4.322, p = 0.036; OR 1.999, 95% CI 1.194-3.348, p = 0.011; OR 2.021, 95% CI 1.203-3.392, p = 0.007), respectively.

conclusionsThe presence of the TaqI A1 allele in Mexicans is a genetic risk factor for detrimental dietary quality that may predispose to metabolic disturbances. LEVEL OF EVIDENCE: Level III, case-control analytic study.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideAdultAllelesCase-Control StudiesCross-Sectional StudiesDietFeeding BehaviorFemaleGene FrequencyGenotypeHumansMaleMexicoMiddle AgedProtein Serine-Threonine KinasesANKK1 protein, humanDRD2 protein, humanProtein Serine-Threonine KinasesReceptors, Dopamine D2DopamineDopamine receptorsDyslipidemiaFood behaviorObesity

Identifiers

PMID30353454
OpenAlexW2898177981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.